Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA)

46 filings reported holding VRNA - Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share as of Q2 2022.
Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 34.8M shares of 84.2M outstanding shares and own 41.32% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (5.69M shares), NEA Management Company, LLC (5.11M shares), RA CAPITAL MANAGEMENT, L.P. (5.1M shares), WELLINGTON MANAGEMENT GROUP LLP (3.83M shares), PERCEPTIVE ADVISORS LLC (2.92M shares), Vivo Capital, LLC (2.75M shares), Abingworth LLP (2.46M shares), Aisling Capital Management LP (1.33M shares), Samsara BioCapital, LLC (1.11M shares), and Foresite Capital Management III, LLC (1.11M shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.